VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1062244
Sex: M
Age:
State: KS

Vax Date: 01/27/2021
Onset Date: 02/05/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: Test Date: 20210205; Test Name: Covid-19; Result Unstructured Data: Test Result:Positive; Test Date: 20210211; Test Name: Covid-19; Result Unstructured Data: Test Result:Positive; Comments: He went again yesterday to be tested and tested positive

Allergies:

Symptoms: received first dose of the covid-19 vaccine on 27Jan2021, he tested positive for covid-19 on 05Feb2021; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. This male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at single dose on 27Jan2021 for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated that received first dose of the covid-19 vaccine on 27Jan2021, he tested positive for covid-19 on 05Feb2021 with outcome of unknown. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 05Feb2021, sars-cov-2 test: positive on 11Feb2021 (He went again yesterday to be tested and tested positive). He asked if he should receive the second dose of the vaccine next Wednesday. Information on the Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 1062245
Sex: M
Age:
State: KS

Vax Date: 02/04/2021
Onset Date: 02/07/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: Test Date: 2021; Test Name: blood work; Result Unstructured Data: Test Result:all good

Allergies:

Symptoms: Bell's Palsy caused the side of my face to swell up and droop on one side; Eyes have been bothering him and he is blinking; Can't talk very good because his lips are swelled up/hard to talk; This is a spontaneous report from a contactable consumer reporting for himself. A 78-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EM9809/expiration date: not provided), via intramuscular route of administration, on 04-FEB-2021 at 14:30 (at the age of 78 years old) 0.3mL as a single dose in the right arm for COVID-19 IMMUNIZATION. Relevant medical history included patient was diabetic since an unknown date and has psoriatic arthritis. Concomitant medication included infliximab (REMICADE) infusion every 8 weeks for psoriatic arthritis and cetirizine hydrochloride (EQUATE ALLERGY RELIEF). The patient had infliximab infusion the morning of 04Feb2021, prior to receiving the vaccination and was told that infliximab would not be a problem with receiving the vaccination on the same day. On 07Feb2021, the patient went to the emergency room due to Bell's palsy, which was described as swelling of lips, nose, mouth, and side of face and stated that he can't talk very good because his lips are swelled up/hard to talk and his eyes have been bothering him and he is blinking. The patient stated, "I went to the emergency room at a hospital and what they said is totally unrelated to the COVID shot I got. In the meantime, few days after I had the shot, I had somehow got Bell's palsy caused the side of my face to swell up and droop on one side. I just wanted to get back to you so you knew that was not some reaction to the COVID shot, it was something else." Treatment for the event Bell's palsy included took Allergy Relief Equate 25mg ultra tablet and another allergy pill and it did not help swelling of lips, nose, mouth, and side of face. Relevant tests included blood work on an unspecified date in 2021 "two weeks ago" that was all good. The outcome of the events Bell's palsy, eyes have been bothering him and he is blinking and hard to talk was unknown.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of event Bell's palsy cannot be totally excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: REMICADE

Current Illness:

ID: 1062246
Sex: F
Age:
State:

Vax Date: 02/05/2021
Onset Date: 02/01/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: cognitive issue (dementia); This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on 05Feb2021, at a single dose, for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Feb2021, the patient experienced cognitive issue (dementia). The patient wanted to know about her second dose schedule. Outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1062247
Sex: F
Age:
State: ME

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: was admitted in the hospital last Friday morning for Pneumonia; This is a spontaneous report from a Pfizer-sponsored program COVAX US Support from a contactable consumer. This female patient of unknown age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown), dose 1, single dose via an unspecified route of administration on an unknown date for COVID-19 vaccination. Medical history includes unspecified underlying conditions. The patient was on unspecified concomitant medications. On an unknown date, the patient had pneumonia and was admitted to the hospital on 05Feb2021. The patient is on oxygen at night while asleep. The clinical outcome of pneumonia was unknown. The reporter doubts if it is related to the Pfizer vaccine The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: The event pneumonia more likely represent an intercurrent medical condition which was not related to BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE).

Other Meds:

Current Illness:

ID: 1062248
Sex: M
Age:
State: NY

Vax Date: 02/04/2021
Onset Date: 02/08/2021
Rec V Date: 03/01/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: dizziness; This is a spontaneous report from a Pfizer-sponsored program Covax US Support, received from a contactable consumer (patient's daughter). A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 04Feb2021 as a SINGLE DOSE for COVID-19 vaccination. The patient's medical history and concomitant medications were not reported. The patient experienced horrible dizziness on 08Feb2021 that resulted in being hospitalized on unknown date. Outcome of the event was unknown. Information on batch/lot number was requested.

Other Meds:

Current Illness:

ID: 1062249
Sex: M
Age:
State: NC

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: Passed out; This is a spontaneous report from a contactable consumer (patient's mother) from a Pfizer-sponsored program. A male patient of an unspecified age received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medications were not reported. On an unspecified date, the patient experienced: passed out (hospitalization, medically significant). The patient's mother called-in on-behalf of her son who passed out in a restaurant and was taken into the hospital due to this emergency. The patient's mother was worried saying that her son was due for the second dose of the COVID-19 vaccine. The patient's mother was unable to identify when her son received the first shot of the vaccine. The patient's mother was also unable to identify why her son passed out. The mother's concern was that her son already missed the second dose. The clinical outcome of the event, passed out, was unknown. The batch/lot numbers for the vaccine, bnt162b2, were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1062250
Sex: F
Age:
State: VA

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Diagnosed with cellulitis; This is a spontaneous report from a contactable nurse (patient). A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient was diagnosed with cellulitis on an unspecified date. Therapeutic measures were taken as a result of the event and included treatment with KEFLEX for 10 days. The patient outcome of the event was unknown. The information on the batch number has been requested.; Sender's Comments: The information currently available is limited and does not allow a meaningful case assessment. Based solely on an implied temporal association causality between event cellulitis and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be completely excluded. The case will be reevaluated should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1062251
Sex: M
Age:
State: CA

Vax Date: 02/02/2021
Onset Date: 02/05/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: Test Date: 20210207; Test Name: Fever; Result Unstructured Data: Test Result:102; Test Date: 20210207; Test Name: Fever; Result Unstructured Data: Test Result:100.2; Comments: A few hours ago it was 102.00 but she got it down to about 100.2 now

Allergies:

Symptoms: Fever; belly is swollen; hurting; hard for him to breath/moves and exerts, his breathing is labored; extremely tired; muscle pain, aches; extreme chills/shivering; shaking; Joint pain; This is a spontaneous report from a contactable consumer. A 76-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection, lot number: EL3248, expiry date not reported), via an unspecified route of administration on 02Feb2021 11:00 at a single dose in the left arm for COVID-19 immunization. Medical history included ongoing atrial fibrillation (reported he has had no occurrence for 3-4 years); and high blood pressure and high cholesterol, both from an unknown date and unknown if ongoing; and pneumonia. Concomitant medications included that patient was also taking high blood pressure medication and high cholesterol medication. When asking for the Lot number, reporter explained "his card was in his wallet but she gave her lot and said it was the same, they got the shot at the same time, within 5 minutes of each other". Patient previously took amoxicillin for pneumonia from 09Jan2021 to 13Jan2021, reported as he took this for 5 days and stopped. This was reported as "It was noted that he had pneumonia and got an antibiotic that he took for 5 days. It was amoxicillin and was started on 09Jan2021" (pending clarification). Reporter also stated that she was not sure if it was a Pfizer vaccine but patient did have a mild reaction to the first shingles vaccine (unspecified) but this lasted only 24 hours. Reporter, a wife calling for her husband (patient), was reporting on the COVID vaccine and who explained he was having symptoms and wanted to report this but also has a question on what to do. Patient was extremely tired. This was noticed on the 3rd day after the shot. This would be Friday 05Feb2021 and it was the same since starting. There were moments when he has rested and showered where he felt better but then it went down again. The patient had muscle pain, aches on 05Feb2021, this would be Friday, and it came and went but was about the same. Patient had extreme chills on 05Feb2021, and he was still shaking now (05Feb2021). It was a little better during the day, maybe because he was moving around but last night he was shivering and shaking for 3 hours and she could not get him warm even with the heating pad. Patient also had joint pain on 05Feb2021 and it was the same since starting. Patient had fever that probably started Sunday, 07Feb2021 wherein few hours ago, it was 102.00 but she got it down to about 100.2 now, it has increased and was the reason she called today. Patient's belly was swollen since 05Feb2021 and it was the same since starting. She remarked she was not sure if this was where lymph nodes were or not and the cause of the swelling. It was also explained that due to hurting, it was hard for him to breath. When he moved and exerted, his breathing was labored. This would be Friday, 05Feb2021 and it is the same since starting. Yesterday, patient went to his primary doctor. He was supposed to do blood work but couldn't due to his fever. The doctor prescribed him an anti-inflammatory called Etodolac 500mg. It was by Taro Pharmacutal US (there was no Lot or expiry). He took one at 7pm and was to take them twice a day, took another a little while ago. Reporter explained she has heard stories where the second dose is worse, and wanted to know if that is true. She also wanted to know if the product Etodolac, has side effects that are similar to what patient was experiencing, and wouldn't taking that make the side effects double worse. Therapeutic measures were taken as a result of the events extreme chills/shivering, shaking, joint pain, and fever. The events extremely tired, muscle pain, aches, extreme chills, shaking, joint pain, fever, belly was swollen, hurting, and "hard for him to breath/moved and exerted, his breathing was labored" were not recovered

Other Meds:

Current Illness: Atrial fibrillation (no occurrence for 3-4 years)

ID: 1062252
Sex: F
Age:
State: VA

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: Test Date: 20210212; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Mental fog; Massive head consuming headache; Extreme fatigue; This is a spontaneous report from a contactable other hcp. A 46-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EL9264), via an unspecified route of administration arm right single dose on 05Feb2021 for COVID-19 immunisation. First dose lot#EL8982, arm right (IM) was received on 15Jan2021, 10:00. Medical history included drug hypersensitivity (to sulfa drugs) from an unknown date. The patient's concomitant medications were not reported. The patient experienced mental fog on 05Feb2021 15:00, massive head consuming headache on 05Feb2021 15:00, extreme fatigue on 05Feb2021 15:00. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 12Feb2021. The events outcome was recovered in Feb2021 No follow-up attempts are possible. No further information is expected; Sender's Comments: Based on the information currently available, a causal relationship between event "mental fog" and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1062253
Sex: F
Age:
State:

Vax Date: 01/20/2021
Onset Date: 02/10/2021
Rec V Date: 03/01/2021
Hospital: Y

Lab Data: Test Date: 20210209; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Shingles; This is a spontaneous report from a non-contactable non-healthcare professional reporting for a patient. A 72-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 20Jan2021 (at the age of 72-years-old) as a single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was tested for COVID-19 post vaccination by nasal swab on 09Feb2021 which had negative results. The patient did not receive other vaccines within 4 weeks prior to vaccination. On 10Feb2021, the patient experienced shingles. The patient was hospitalized for the event on an unknown date for 2 days. It was unknown if the patient received treatment. The clinical outcome of the event shingles was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1062254
Sex: F
Age:
State: ME

Vax Date: 01/21/2021
Onset Date: 02/01/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pain in lymphoma area; pain in lymphoma area; Multiple headaches; neck pain; inner ear pressure; jaw pain; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot: EL3247), via an unspecified route of administration in the left arm on 21Jan2021 at 11:45 (at the age of 60-years-old) as a single dose for COVID-19 immunization. Medical history included type 2 diabetes and overweight, and the patient had no known allergies. The patient was not diagnosed with COVID-19 prior to the vaccination. Concomitant medications included lisinopril, metformin, metoprolol, sitagliptin (JANUVIA). The patient did not receive any other vaccine within 4 weeks of the vaccination. On 01Feb2021 at 09:00, the patient experienced multiple headaches, neck pain, pain in lymphoma area, inner ear pressure, jaw pain. The patient was not treated for the events. Since the vaccination, the patient was not tested for COVID-19. The clinical outcomes of multiple headaches, neck pain, pain in lymphoma area, inner ear pressure, jaw pain was resolving.

Other Meds: LISINOPRIL; METFORMIN; METOPROLOL; JANUVIA [SITAGLIPTIN]

Current Illness:

ID: 1062255
Sex: M
Age: 75
State: CA

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies: Aspirin

Symptoms: 1. Woke up following morning , I had difficulty urinating. 2. 99.3 fever the following day around 4 pm. Took 2 tablets of tylenol. 3. Fever gone after a few hours. 4. Still had difficulty urinating whole day up to evening of the 2nd day.

Other Meds: 10 milligrams Fosinopril

Current Illness:

ID: 1062256
Sex: M
Age: 50
State: CA

Vax Date: 01/13/2021
Onset Date: 03/01/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies: None

Symptoms: Within 5 minutes I Became extremely hot. It started from feet up to face, heart palpitations. I could feel my heart beating in my chest. Uneasy feeling, something was wrong. Dizzy, remained with ice pack and wet towel for 20 minutes. After I left I felt off and dizzy. I had a difficult time driving . That evening I had soreness at injection site for 3 days. Headache and dizziness for 3 days. Chills for 1 day. Back pain and hip pain still to this day.

Other Meds: 12.5 mg xanax 12.5 mg carvedilol 10 mg citalopram 5 mg amlodipibe

Current Illness: None

ID: 1062257
Sex: F
Age: 54
State: IN

Vax Date: 02/27/2021
Onset Date: 03/01/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: none

Allergies: none

Symptoms: Woke up twice not really feeling right. Restless sleep and woke up the second time with stomach upset as if going to have diarrhea. minor lower stomach cramping. Did have a bowel movement within 2 hours that was soft with lower abdominal discomfort but wasn't diarhhea. Felt as if a headache was starting

Other Meds: Multi Vitamin, zinc, magnesium, probiotic, Armour thyroid 90 mg, Valsartin 320/25

Current Illness: none

ID: 1062258
Sex: F
Age:
State: NY

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Lost 100% of vision in left eye and 50% of vision in right eye; Numbness of face and neck; Numbness of face and neck; Swelling of face and neck; Swelling of face and neck; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, Manufacturer Pfizer BioNTech, lot number EN6201), via an unspecified route of administration in right arm, on 10Feb2021 at 15:45, at single dose, for COVID-19 immunisation. Medical history included blood cholesterol increased. Patient did not have known allergies, did not have COVID-19 prior to vaccination and was not pregnant at time of events or vaccination. There were no concomitant medications. Patient did not receive other different vaccines in four weeks. Previously the patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer BioNTech, lot# EL3244), in arm left, on 20Jan2021 at 15:45, for COVID-19 immunisation. The patient experienced lost 100% of vision in left eye and 50% of vision in right eye on 10Feb2021 at 17:30 with outcome of recovered on 11Feb2021 at 07:30 (after 14 hours), numbness of face and neck on 10Feb2021 at 17:30 with outcome of recovered on 12Feb2021 at 09:30 (after 40 hours), swelling of face and neck on 10Feb2021 at 17:30 with outcome of recovered on 12Feb2021 at 09:30 (after 40 hours). Patient did not tested positive for COVID-19 after vaccination. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1062259
Sex: F
Age: 65
State: FL

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies: NO

Symptoms: ?Pfizer-BioNTech COVID-19 Vaccine EUA?

Other Meds: SPIRONOLACTONE 50MG VIT C 500MG VIT B12 100MCG TUMERIC COQ10 100 MG ATORVASTATIN CALCIUM 10MG FISH OIL 1000MG IBUPROFEN 800 MG LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25MG

Current Illness: VENOUS US to r/o venous reflux PHARMACOLOGIAL NUCLEAR STRESS TEST TO r/o MYCARDIAL ISCHEMIA F/U FOR RESULTS

Date Died: 02/28/2021

ID: 1062260
Sex: F
Age: 99
State: NY

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies: none

Symptoms: Developed acute facial droop and slurred speech 2h after 1st dose of the vaccine on 2/17, found with R MCA stroke. Then became unresponsive on 2/27 and was found with an acute L MCA stroke. Was transferred from another hospital, was not a candidate for intervention, and was made comfort and died on 2/28

Other Meds: warfarin

Current Illness:

ID: 1062261
Sex: M
Age: 37
State:

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: All tests and labs 26 Feb 20121 ECG, sinus bradycardia CBC, CMP, Troponin, UA (all WNL)

Allergies: None

Symptoms: Patient was brought to clinic by ambulance for an unwitnessed syncopal event with LOC for unknown period of time. He reported no memory of event. No post-ictal confusion when found. Upon arrival in clinic, patient reported headache, mild confusion, bilateral facial numbness across cheeks and forehead, pressure behind eyes, light sensitivity, and nausea with eye movement. Time between receiving vaccine and event possibly 2 hours. Following assessment in clinic, patient was referred to emergency department for further evaluation.

Other Meds: None

Current Illness: None

ID: 1062262
Sex: M
Age:
State: GA

Vax Date: 02/18/2021
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Experiencing extreme itching on site of vaccine.; This is a spontaneous report from a contactable consumer reported for himself. A 78-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), from lot # EN6201, via unknown route at left arm on 18Feb2021 at 12:15 (at the age of 78-year-old) at single dose for covid-19 immunization. The patient received the first dose of the same vaccine on 28Jan2021 at 12:15 AM at the left arm from lot # EL3248. The patient experienced extreme itching on site of vaccine. The outcome of the event was not recovered. No COVID prior vaccination. Patient has not been tested for COVID-19. Adverse event result in hospitalization, Life threatening illness, Disability or permanent damage, Congenital anomaly.

Other Meds:

Current Illness:

ID: 1062263
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: Thrombocytopenia; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) at single dose, on an unspecified date, for COVID-19 immunisation. Relevant medical history and concomitant medications were unknown. On an unspecified date, the patient experienced thrombocytopenia. Hospitalization required. Clinical outcome of the adverse event was unknown at time of this report. No follow-up attempts are possible, information about lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1062264
Sex: F
Age:
State: CO

Vax Date: 02/13/2021
Onset Date: 02/13/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Patient fainted and hyporesponsive.; Patient fainted and hyporesponsive.; This is a spontaneous report from a non-contactable other healthcare professional. A 21-year-old non-pregnant female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot number: En9265, intramuscular on 13Feb2021 at 14:00 (at the age of 21 years old) as a single dose in the right arm for COVID-19 vaccination. The patient's medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient fainted and was hyporesponsive on 13Feb2021. The patient did not receive treatment for the events. The outcome of the events was recovered in Feb2021. It was also reported that since the vaccination, the patient had not been tested for COVID-19. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on vaccine-event chronological association, a causal relationship between events fainted and was hyporesponsive and BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1062265
Sex: F
Age:
State: ID

Vax Date: 02/03/2021
Onset Date: 02/06/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: left arm painful; This is a spontaneous report from a contactable nurse (patient). An 86-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL9265), via an unspecified route of administration in the left arm, on 03Feb2021 at 12:05 (at the age of 86-years-old) at a single dose for COVID-19 immunization. The patient had no medical history or concomitant medications. The patient had no family history related to the adverse events. The patient had no prior adverse events to vaccinations nor any prior vaccinations within four weeks of vaccination. There were no additional vaccines administered on the same day. The patient experienced left arm painful on 06Feb2021, which was reported with disability. The clinical course was reported as follows: The first 3-4 days (as reported), there were no side effects; however, her arm was painful for days 5- 7, and on day 9, it was still a little sore but better. Therapeutic measures were taken as a result of the event, which included a visit to the chiropractor. The clinical outcome of left arm painful was recovering. The primary reporter (patient) assessed the causality between the event and the suspect product as related.; Sender's Comments: Based on the information available, a causal relationship between event "left arm painful" and BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1062266
Sex: F
Age:
State: TX

Vax Date: 01/20/2021
Onset Date: 02/06/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: preseptal cellulitis eyelid; hurt her back, aggravating the back pain; hurt her back, aggravating the back pain; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL9261), via an unspecified route of administration in the right arm on 20Jan2021 at 14:00 (at the age of 63-years-old) as a single dose for COVID-19 immunization. Medical history included breast cancer from 2015, back pain (which predated vaccination with BNT162B2), cholesterol, diabetes, blood pressure, kidney stones, vitamin D low, allergy, depression, lichen sclerosus and hair loss. Ongoing concomitant medications included simvastatin for cholesterol, empagliflozin (JARDIANCE) for diabetes, metformin for diabetes from 20Dec2020, linagliptin (TRADJENTA) for diabetes, hydrochlorothiazide/valsartan for blood pressure, potassium citrate (UROCIT-K) for kidney stones, vitamin D for vitamin D low, fexofenadine hydrochloride (ALLEGRA) for allergy, anastrozole (ARIMIDEX) for depression, clobetasol propionate for lichen sclerosus, lidocaine hydrochloride (ASPERCREME WITH LIDOCAINE) for back pain, minoxidil for hair loss. There were no additional vaccines administered on the same date as BNT162B2, and no vaccinations within 4 weeks prior of BNT162B2. On 06Feb2021, the patient hurt her back, aggravating the back pain. On 06Feb2021, the patient experienced preseptal cellulitis of the eye lid. The events required a visit to the emergency room and physician office but did not require admission to the hospital. The patient went to the doctor on 06Feb2021 for preseptal cellulitis of the eyelid and was treated with cephalexin 250 mg orally four times a day from 06Feb2021 to 11Feb2021, and dexamethasone/neomycin/ polymyxin b (NEOPOLYDEX) from 06Feb2021 and ongoing three times per day. On 08Feb2021, the patient took paracetamol (TYLENOL) 500 mg for the back pain. The patient went to the doctor for the back pain on 11Feb2021 and was prescribed meloxicam 15 mg once daily and cyclobenzaprine 10 mg, (take one half by mouth as needed). Reportedly, the cyclobenzaprine did absolutely nothing. The patient also took paracetamol (TYLENOL ARTHRITIS) 650 mg per her doctor's recommendation. The clinical outcome of preseptal cellulitis eyelid was resolving, and of "hurt her back, aggravating the back pain" was not resolved.

Other Meds: SIMVASTATIN; JARDIANCE; METFORMIN; TRADJENTA; VALSARTAN HYDROCHLOROTHIAZIDE KRKA; UROCIT-K; VITAMIN D [VITAMIN D NOS]; ALLEGRA; ARIMIDEX; CLOBETASOL PROPIONATE; ASPERCREME WITH LIDOCAINE; MINOXIDIL

Current Illness:

ID: 1062267
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: H.pylori infection; had a really bad headache; sore left arm / hurt and ached all the way down and when trying to open it hurt / could only lay on her back and not her side because it hurt; Chills; she hardly slept all night; She can hardly raise her left arm; has a big bump to left arm; quarter size red area and redness all around the area to left arm; This is a spontaneous report from a contactable consumer (patient). This 55-year-old female patient received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date at 15:00, for COVID-19 immunization. The first BNT162B2 vaccine dose was given on an unknown date. Medical history included ongoing hypertension; she was taking two unspecified medications already. The day following vaccination, the patient experienced a really bad headache, arm sore and chills. She left work, went home and felt like she started to feel better. She hardly slept all night and her left arm hurt and ached all the way down and when trying to open it hurt. She can hardly raise her left arm, it hurt so bad. On left arm she had a big bump and quarter size red area and redness all around the area. She was having headache again. She could only lay on her back and not her side because it hurt. At 3:30 she took paracetamol (TYLENOL) and that took the edge off. On an unspecified date in Feb2021 she was diagnosed with H. pylori infection and had been on an antibiotic. She took ibuprofen (ADVIL) at about 8:30 and put heating pad on her arm. She was regretting the vaccine because she did not know that it would be this bad. Events outcome was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness: Hypertension (she was taking two unspecified medications already)

ID: 1062268
Sex: F
Age:
State:

Vax Date:
Onset Date: 12/30/2016
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Diarrhea; nausea; vomiting; GI Upset; This is a spontaneous report from a contactable physician and consumer. A 69-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13; lot number and expiration date: unknown), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced diarrhea, nausea, vomiting, GI upset on 30Dec2016. Outcome of the events was unknown. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1062269
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: when patient got the flu shot had at least 5 sinus infections a year; Initial information was received on 11-Feb-2021 regarding an unsolicited valid non-serious case received from a consumer or non-health care professional via social media. This case involves a patient (unknown age and gender) who experienced sinus infections (at least 5) a year (sinusitis), while he/she received vaccine INFLUENZA VACCINE. It was unknown if the patient had any medical history, concomitant disease or risk factor and the patient's past medical treatment(s), vaccination(s), family history and concomitant medication were not reported On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number; dosing details and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination. On an unknown date, the patient developed non-serious sinus infections (at least 5) a year (sinusitis) (Unknown latency) following the administration of INFLUENZA VACCINE. It was reported that patient had not had that poison for three years then and had not been sick once before that. It was unknown if the patient experienced any additional symptoms/events. Medication details and reason for taking the medicine: Not provided Details of laboratory data were not reported. It was not reported if the patient received any corrective treatment. At the time of reporting, outcome of the event was unknown. Result of assessment was not reported. There will be no information available on batch number for this case.

Other Meds:

Current Illness:

ID: 1062270
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: patient get more sick; Initial information received on 16-Feb-2021 regarding an unsolicited valid non-serious case from non-healthcare professional. This case involves patient (unknown demographics) who get more sick (illness), after receiving INFLUENZA VACCINE. Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On an unknown date, the patient received dose of suspect INFLUENZA VACCINE produced by unknown manufacturer [lot number and expiry date not reported] via unknown route in an unknown administration site for prophylactic vaccination. On an unknown date, the patient get more sick (illness) (non-serious) (Unknown latency), following the administration of INFLUENZA VACCINE. No laboratory data reported. It was not reported if the patient received a corrective treatment. At the time of reporting, the outcome is unknown for illness. There will be no information on the batch number to be requested for this case.

Other Meds:

Current Illness:

ID: 1062271
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: allergic to them; Initial information received on 17-Feb-2021 regarding an unsolicited valid non-serious case from a social media via consumer or non-health care professional. This case involves adult patient (gender not specified) who was allergic to them (Allergy to vaccine), while patient received INFLUENZA VACCINE. It was unknown if the patient had any medical history, concomitant disease or risk factor. Past medical treatment, vaccination and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination. On an unknown date, the patient developed a non-serious allergic to them (allergy to vaccine) unknown latency following the administration of INFLUENZA VACCINE. It was unknown if the patient experienced any additional symptoms/events. It was unknown if there were lab data/results available. It was not reported if the patient received any corrective treatment. At the time of reporting, the event outcome reported as unknown for event. The reporter assessed the causal relationship with suspect vaccine as related. There will be no information available on the batch number for this case.

Other Meds:

Current Illness:

ID: 1062272
Sex: F
Age:
State: KY

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Administered 2 vaccines (Adacel and Flublok) to a pregnant patient, with no reported adverse event; Initial information regarding an unsolicited valid non-serious case was received from a pharmacist via Medical Information (Reference number- 00479733) and transmitted to Sanofi on 17-Feb-2021. This case involves a 28 years old female patient who was exposed to vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] in context of administered two vaccines (adacel and flublok) to a pregnant patient (Exposure during pregnancy). Data regarding this pregnancy were received prospectively. The date of last menstrual period was not reported. The estimated due date is 05-Apr-2021. Medical history, medical treatment, vaccination and family history were not provided. Concomitant medications included INFLUENZA VACCINE RHA 3V (BACULOVIRUS) (FLUBLOK). On an unknown date, the patient received a 0.5 mL dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [lot U6846AA and expiry date: 16-Oct-2022] via an intramuscular route in right arm for prophylactic vaccination. It was reported that, vaccine presentation for specific vaccine if baby was delivered: delivery date and if baby experienced an adverse event- not delivered. Inform that they would be receiving a follow up questionnaire and it was done. All pregnancy cases were added to the registry, it was an FDA requirement. Product used: Used. Still using product: No. It was the case of vaccine exposure during pregnancy [Latency on the same day]. Pregnancy outcome was unknown at the time of report. Details of laboratory data not reported. There will be no information available on the batch number for this case.

Other Meds: FLUBLOK

Current Illness:

ID: 1062273
Sex: F
Age: 27
State: NY

Vax Date: 02/28/2021
Onset Date: 02/28/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: CBC-RESULTS WITHIN NORMAL LIMITS, CMP- RESULTS WITHIN NORMAL LIMITS

Allergies: SHELLFISH, POLLEN

Symptoms: URTICARIA, THROAT TIGHTNESS, EYELID SWELLING

Other Meds: SUMATRIPTAN, EXEDRIN PM, RIBOFLAVIN, MAGNESIUM SUPPLEMENT, COQ10, BIENVA BIRTH CONTROL

Current Illness: MIGRAINE HEADACHES, PREDIABETES, ECZEMA, HIGH TRIGLYCERIDES, VERTIGO

ID: 1062274
Sex: F
Age: 65
State: MI

Vax Date: 02/26/2021
Onset Date: 02/28/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: None

Allergies: Ceclor, shellfish

Symptoms: Nausea, vomitting, diarhea, dizziness

Other Meds: Keppra 500 mg twice a day.

Current Illness: None

ID: 1062275
Sex: F
Age: 41
State: OH

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies: Sulfa Cupronickel

Symptoms: Within 10 minutes: anxiety, dizziness Within 1 hour: diarrhea, anxiety, mild trouble breathing 2 days later: trouble breathing, mild fever

Other Meds: Gabapentin Qvar Ventolin

Current Illness:

ID: 1062276
Sex: F
Age: 34
State: OH

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: None

Allergies: None

Symptoms: 103 fever from 10:30 pm-7 am. Low grade fever 100 from 7am-3pm. Headache(24 hrs), nausea(during high fever period), chills(during high fever period), fatigue (34 hours)

Other Meds: Ibuprofen

Current Illness: None

ID: 1062277
Sex: M
Age: 39
State: WA

Vax Date: 02/23/2021
Onset Date: 02/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies: None

Symptoms: Hives 3.5 days after 2nd vaccination was administered, along with transient lower lip swelling. Eye swelling appeared 5 days after vaccination.

Other Meds: None

Current Illness: None

ID: 1062278
Sex: M
Age: 54
State: FL

Vax Date: 02/02/2021
Onset Date: 02/15/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: NONE

Allergies: NONE

Symptoms: Rash on arms, legs, back, stomach, chest & back. treated with Benedryl Cream and Aveeno Bath Power. Starting to go away on 1 Mar 21

Other Meds: K Phos, Darunavir, Abacavir, Lisinopril, Nifedipine, Ritonavir, Vitamin D

Current Illness: NONE

ID: 1062279
Sex: F
Age: 38
State: NJ

Vax Date: 02/16/2021
Onset Date: 02/17/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: None

Allergies: No know allergies

Symptoms: 24 hrs post first dose 1 lymph node last side of neck swollen, hard, immobile, and painful. 48 hrs post first dose lymph nodes through left armpit and left proximal upper arm swollen, hard, immobile, and painful. 60 hrs post first dose lymph nodes throughout left arm swollen, hard, immobile, and painful. Arm generalized +1 edema. Pain 3 on scale of 1-10. Currently 13 days post dose. Arm remains unchanged.

Other Meds: Adderrall xr Kyleena IUD

Current Illness: No illness

ID: 1062280
Sex: F
Age: 50
State: VA

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies: None

Symptoms: Covid arm. Swelling, pain, big rash, itchy, firmness under skin (knots)

Other Meds: None

Current Illness: None

ID: 1062281
Sex: F
Age: 49
State: VA

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: Note noted

Allergies: Emycin, tetracycline, sulfa, penicillin, Vicodin -- rash. Latex -- contact rash.

Symptoms: Waited 30 min in vaccine clinic with no problems. Approx 2 hours after vaccination, experienced diffuse itching with oral paresthesia and cough. No globus or SOB. Seen in Urgent Care. No hives or other rash recorded. Vital signs stable. Treated with oral decadron and benadryl and released after >1 hour observation with resolution of sxms.

Other Meds: None reported

Current Illness: None reported

ID: 1062282
Sex: M
Age: 34
State: IN

Vax Date: 02/03/2021
Onset Date: 02/18/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies: Lactose

Symptoms: Severe joint pain in left arm - specifically elbow, hand

Other Meds: COSENTYX 150 MG, Zyrtec, Aleve. Sertaline 25 mg, adderall 5 mg, omeprazole

Current Illness: None

ID: 1062283
Sex: F
Age: 68
State: CT

Vax Date: 02/28/2021
Onset Date: 03/01/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies: None

Symptoms: None

Other Meds: Lexapro, hydrochlorothizide,potassium,lorazepam,restasis,calcium

Current Illness: None

ID: 1062284
Sex: M
Age: 80
State: VA

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: none

Allergies: Pencillin

Symptoms: Dizzness Upset stomach Blurry eyes Hot in face Anxiousness Fatigue

Other Meds: Valsartan 160 mg D3- 5000iu HCTZ 12.5 mg probiotic amlodipine 10 mg

Current Illness: none

ID: 1062285
Sex: M
Age: 64
State: NJ

Vax Date: 02/22/2021
Onset Date: 02/23/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: none

Allergies: None

Symptoms: Chills, then mild fever, muscle aches, head ache

Other Meds: Losartan 50MG, super Omega 3 , Magnesium Citrate, Vitamin D3 5000,

Current Illness: None

ID: 1062286
Sex: F
Age: 49
State: IN

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies: None

Symptoms: Muscle pain, fatigue, chills, headache

Other Meds: Levothyroxine Escitalopram Oxybutynin

Current Illness: None

ID: 1062287
Sex: F
Age: 73
State: NJ

Vax Date: 02/01/2021
Onset Date: 02/19/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache nausea chills weakness severe arm pain right arm . Recovered in 10 hours followed by slight headache for several days.

Other Meds: Thyroxide HCTZ multi vitamin lipitor

Current Illness:

ID: 1062288
Sex: F
Age: 46
State: HI

Vax Date: 02/01/2021
Onset Date: 02/09/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: None

Allergies: None

Symptoms: Rash all over body for three weeks now; started on torso and slowly spread. Itchiness prevents sleeping through the night.

Other Meds: Quantum Health Super Lysine (immunity)

Current Illness: None

ID: 1062298
Sex: F
Age: 40
State: AZ

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: none

Allergies: Bactrum

Symptoms: pain in arm, slight redness and swelling at the injection site

Other Meds: levothyroxine, Isibloom

Current Illness: None

ID: 1062299
Sex: F
Age: 68
State: IL

Vax Date: 02/25/2021
Onset Date: 02/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: None

Allergies:

Symptoms: Chills, dizziness, nausea, vomiting, diarrhea, fatigue

Other Meds: Lisinopril 5mg per day

Current Illness: None

ID: 1062300
Sex: F
Age: 71
State: ME

Vax Date: 02/12/2021
Onset Date: 02/28/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: None so far

Allergies: Codeine

Symptoms: I have a large red square on my arm just below the injection site...........it is about 2x3 inches and itches

Other Meds: Armour thyroid........Vitamins C, Zinc, Lutein, Biotin, Saw Palmetto, D3, Fish Oil, Ubiquinol

Current Illness: None

ID: 1062302
Sex: F
Age: 59
State: MI

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies: Gelatin Wheat Gluten

Symptoms: 35 minutes after vaccine: Slight headache & slight nausea 6 hours after vaccine: Left upper arm extremely stiff & tender. Tired/sleepy feeling. 8 hours after vaccine: EXTREME exhaustion, legs, arms stiff [unable to turn over in bed] (Water/Coffee/Tea intake). 1 day after vaccine: VERY EXTREME exhaustion, difficulty walking, moving. No appetite. No bowel movements(Water/Coffee/Tea intake-very high-very little urination)-slept 10 hours. Vaccination site extraordinarily sore & stiff. Still difficult to turn over in bed. 2 day after vaccine: EXTREME exhaustion occurs in waves. Sleeping over 12 hours-cannot stay awake. Stiffness subsiding. Vaccination site no longer sore, stiffness subsiding. 3 day after vaccine. Still exhausted. stiffness very light. Still require 10 plus hours of sleep.

Other Meds: 1 tablet 'Alive! Garden Goodness' multi-vitamin supplement

Current Illness: None

ID: 1062305
Sex: M
Age: 1
State: TX

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no further AE; temperature excursion; PROQUAD no longer viable; This spontaneous report was received from a nurse referring to a 13 months old male patient. The patient's medical history, concomitant drugs and drug allergies were not reported. On 25-JAN-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # T003714, expiration date was not reported, but upon internal validation established as 29-JUL-2021, strength was not reported) 0.5 milliliter subcutaneously for prophylaxis. It was reported that the office was closed due to coronavirus disease (COVID), and the freezer had gone out of range. The temperature excursion of these vaccine was 47 degrees Fahrenheit for approximate 9 hours and 54 minutes without any previous temperature excursion. The digital data logger was involved for measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD). It was also reported that the measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was no longer viable. No further adverse event was reported.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm